Novel antibody-drug conjugate for pancreatic NET targeted therapy
Renata Jaskula-Sztul, PhD
Funded Research Projects
NETcure—shine new light on neuroendocrine tumor therapy
Martin Gotthardt, PhD
Phase 1 study of SurVaxM ™ in survivin-positive NETs
Renuka Iyer, MD
Evaluation of Ac-225 dotatate for treatment of lung carcinoid tumors
David Morse, PhD
Novel radioligands to improve radiotherapy of NETs
Kuo-Shyan Lin, PhD
NET-smart chemotherapy: a targeted prodrug strategy
Justin Annes, MD, PhD
Understanding the physiologically relevant functions of DAXX
Guillermina (Gigi) Lozano, PhD
Multipronged approaches to develop immunotherapy targeting NETs
Xianxin Hua, MD, PhD
New strategies to improve drug development for carcinoid tumors
Emily Bergsland, MD
Intra-arterial Peptide Receptor Radionuclide Therapy (IA-PRRT) using 90Y-DOTA-TOC
Thomas Hope, MD